Qinglong Tuomin Decoction in the treatment of children with allergic rhinitis: a randomized, double-blind clinical study T

INTERVENTION: observation group:Qinglong Duomin Decoction;observation group:Levocetirizine hydrochloride placebo;control group:Levocetirizine Hydrochloride;control group:Qinglong Duomin Decoction placebo; CONDITION: allergic rhinitis PRIMARY OUTCOME: TNSS;VAS;TCM Syndrome Score; SECONDARY OUTCOME: TNNSS;Quality of life score for children with allergic rhinitis;serum specific IgE;Nasal Acoustic Refle XMeasurement; INCLUSION CRITERIA: (1) Those who meet the diagnostic criteria of western medicine and traditional Chinese medicine for allergic rhinitis, voluntarily take the test and sign the informed consent; (2) Age: 3‐14 years old, gender is not limited; (3) Those who have not used hormones, immunosuppressants and other related drugs that affect the examination and judgment of experimental results one week before inclusion in this study; (4) The patient gave informed consent and voluntarily followed up with the patient and truthfully fed back the information to the patient;